DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

IWP, INTU, VRTX, MHFI: ETF Outflow Alert

Vertex Announces Collaboration with Parion Sciences to Develop ENaC Inhitibors in CF, Pulmonary Dise

Vertex Announces Collaboration with Parion Sciences to Develop ENaC Inhitibors in CF, Pulmonary Diseases

Corbus Focused on Research and in No Hurry for Partnerships, Says CEO

Nasdaq 100 Movers: VRTX, WYNN

The Highest Paid CEOs in Biotech

These highest paid CEOs in biotech brought in a minimum of $24 million in compensation in 2014. Find out what makes these leaders so special, and whether or not their exorbitant pay packages are sustainable.

Vertex Pharmaceuticals Takes Another Step Forward For Cystic Fibrosis Patients

Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter

3 Types of Risks Facing Biotech Stocks

Biotech stocks have been dramatically outperforming the broader market, but that doesn't mean they're free of risk. Here are three types of risks all biotech stocks face.

Could This Tiny Biotech Be on Gilead Sciences’ M&A Radar?

Gilead Sciences is on the the prowl for potential buyout targets. This little-known immuno-therapy company looks like a perfect match for the biotech in many ways. Here's why.

S&P 500 Movers: GMCR, NFLX

See More Articles...